Envista Holdings Corp
NVST20.930USD
-0.100-0.48%
Close 09/19, 16:00（ET）Quotes delayed by 15 min
3.49BMarket Cap
64.89P/E TTM
More Details of Envista Holdings Corp Company
Envista Holdings Corporation is a dental products company. The Company provides dental consumables, solutions, technology, and services. It has approximately 30 dental brands, including Nobel Biocare, Ormco and Kerr united. The Company operates through two segments: Specialty Products & Technologies and Equipment & Consumables. The Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Equipment & Consumables segment develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems, and endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents and cements, and infection prevention products.
Company Info
Ticker SymbolNVST
Company nameEnvista Holdings Corp
IPO dateSep 18, 2019
CEOMr. Paul A. Keel
Number of employees12300
Security typeOrdinary Share
Fiscal year-endSep 18
Address200 S. Kraemer Blvd., Bldg. E
CityBREA
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code92821
Phone17148175418
Websitehttps://envistaco.com/en
Ticker SymbolNVST
IPO dateSep 18, 2019
CEOMr. Paul A. Keel
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Paul A. Keel
Mr. Paul A. Keel
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
87.42K
-12.76%
Ms. Barbara B. Hulit
Ms. Barbara B. Hulit
Independent Director
Independent Director
79.82K
+15.06%
Mr. Stefan Nilsson
Mr. Stefan Nilsson
President - Nobel Biocare
President - Nobel Biocare
54.94K
-1.44%
Ms. Wendy Carruthers
Ms. Wendy Carruthers
Independent Director
Independent Director
50.61K
+26.02%
Ms. Christine A. Tsingos
Ms. Christine A. Tsingos
Independent Director
Independent Director
50.60K
+26.03%
Ms. Veronica Acurio
Ms. Veronica Acurio
President - Orthodontics
President - Orthodontics
50.32K
-9.73%
Mr. Daniel A. Raskas, J.D.
Mr. Daniel A. Raskas, J.D.
Independent Director
Independent Director
44.68K
+30.53%
Mr. Vivek Jain
Mr. Vivek Jain
Independent Director
Independent Director
43.62K
+31.51%
Mr. Mark E. Nance
Mr. Mark E. Nance
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
41.98K
-4.05%
Mr. J. Andrew Pierce
Mr. J. Andrew Pierce
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Paul A. Keel
Mr. Paul A. Keel
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
87.42K
-12.76%
Ms. Barbara B. Hulit
Ms. Barbara B. Hulit
Independent Director
Independent Director
79.82K
+15.06%
Mr. Stefan Nilsson
Mr. Stefan Nilsson
President - Nobel Biocare
President - Nobel Biocare
54.94K
-1.44%
Ms. Wendy Carruthers
Ms. Wendy Carruthers
Independent Director
Independent Director
50.61K
+26.02%
Ms. Christine A. Tsingos
Ms. Christine A. Tsingos
Independent Director
Independent Director
50.60K
+26.03%
Ms. Veronica Acurio
Ms. Veronica Acurio
President - Orthodontics
President - Orthodontics
50.32K
-9.73%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
No Data
By RegionUSD
Name
Revenue
Proportion
Northern America
324.40M
52.59%
Western Europe
143.30M
23.23%
Emerging markets
118.80M
19.26%
Other developed markets
30.40M
4.93%
By Business
By Region
No Data
Shareholding Stats
Updated: Sat, Aug 16
Updated: Sat, Aug 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
10.18%
BlackRock Institutional Trust Company, N.A.
8.84%
Ariel Investments, LLC
7.43%
Atlanta Capital Management Company, L.L.C.
6.51%
Dimensional Fund Advisors, L.P.
5.52%
Other
61.52%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
10.18%
BlackRock Institutional Trust Company, N.A.
8.84%
Ariel Investments, LLC
7.43%
Atlanta Capital Management Company, L.L.C.
6.51%
Dimensional Fund Advisors, L.P.
5.52%
Other
61.52%
Shareholder Types
Shareholders
Proportion
Investment Advisor
55.93%
Investment Advisor/Hedge Fund
47.14%
Hedge Fund
11.32%
Pension Fund
1.46%
Research Firm
1.36%
Sovereign Wealth Fund
1.29%
Individual Investor
0.54%
Bank and Trust
0.50%
Private Equity
0.36%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
735
199.63M
120.11%
-32.52M
2025Q1
767
200.87M
118.49%
-32.33M
2024Q4
774
200.73M
116.58%
-32.33M
2024Q3
769
198.37M
115.33%
-28.47M
2024Q2
775
193.95M
112.83%
-33.23M
2024Q1
793
187.23M
108.93%
-31.14M
2023Q4
800
189.02M
110.25%
-16.86M
2023Q3
779
181.32M
105.90%
-24.06M
2023Q2
772
187.89M
114.71%
-18.52M
2023Q1
783
191.23M
116.82%
-14.97M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
17.02M
10.04%
-218.34K
-1.27%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
15.43M
9.1%
+235.82K
+1.55%
Mar 31, 2025
Ariel Investments, LLC
12.14M
7.17%
+85.12K
+0.71%
Mar 31, 2025
Atlanta Capital Management Company, L.L.C.
12.14M
7.16%
+242.93K
+2.04%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
8.39M
4.95%
+1.63M
+24.03%
Mar 31, 2025
Franklin Mutual Advisers, LLC
7.67M
4.52%
+817.48K
+11.93%
Mar 31, 2025
Harris Associates L.P.
8.68M
5.12%
-740.06K
-7.86%
Mar 31, 2025
American Century Investment Management, Inc.
6.35M
3.75%
-552.57K
-8.00%
Mar 31, 2025
Gates Capital Management, Inc.
5.16M
3.05%
+469.60K
+10.00%
Mar 31, 2025
AllianceBernstein L.P.
4.55M
2.69%
+4.33M
+1985.15%
Mar 31, 2025
View more
Related ETFs
Updated: Tue, Sep 2
Updated: Tue, Sep 2
Name
Proportion
SPDR S&P Health Care Equipment ETF
1.71%
Schwab Ariel Opportunities ETF
1.46%
Harbor Long-Short Equity ETF
0.98%
Royce Quant Small-Cap Quality Value ETF
0.54%
JPMorgan Fundamental Data Science Mid Core ETF
0.53%
Pacer US Small Cap Cash Cows ETF
0.35%
iShares U.S. Medical Devices ETF
0.35%
VictoryShares US Small Mid Cap Value Momentum ETF
0.31%
DFA Dimensional US Small Cap Value ETF
0.28%
Vanguard S&P Mid-Cap 400 Value Index Fund
0.23%
View more
SPDR S&P Health Care Equipment ETF
Proportion1.71%
Schwab Ariel Opportunities ETF
Proportion1.46%
Harbor Long-Short Equity ETF
Proportion0.98%
Royce Quant Small-Cap Quality Value ETF
Proportion0.54%
JPMorgan Fundamental Data Science Mid Core ETF
Proportion0.53%
Pacer US Small Cap Cash Cows ETF
Proportion0.35%
iShares U.S. Medical Devices ETF
Proportion0.35%
VictoryShares US Small Mid Cap Value Momentum ETF
Proportion0.31%
DFA Dimensional US Small Cap Value ETF
Proportion0.28%
Vanguard S&P Mid-Cap 400 Value Index Fund
Proportion0.23%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
